Flora Fertility has secured $1.5 million in pre-seed funding to launch an innovative fertility insurance product aimed at enhancing accessibility and affordability of fertility treatments across the U.S. and Canada.

Target Information

Flora Fertility is an innovative startup that originated from a venture studio, recently securing a $1.5 million pre-seed financing round in October 2024. The financing was led by Highline Beta, and included participation from renowned U.S.-based investors, Cartography Capital and Everywhere Ventures, alongside a select group of strategic angel investors.

This significant funding will enable Flora to introduce its groundbreaking private fertility insurance product across the United States and Canada, thereby enhancing the accessibility and affordability of fertility treatments for millions of individuals and families.

Industry Overview

The fertility industry has been experiencing a robust transformation, particularly in North America, where the demand for fertility services has surged. Factors driving this demand i